Back to Search Start Over

Self‐performed Five Times Sit‐To‐Stand test at home as (pre‐)screening tool for frailty in cancer survivors: Reliability and agreement assessment.

Authors :
van Cappellen‐van Maldegem, Sandra J. M.
Hoedjes, Meeke
Seidell, Jacob C.
van de Poll‐Franse, Lonneke V.
Buffart, Laurien M.
Mols, Floortje
Beijer, Sandra
Source :
Journal of Clinical Nursing (John Wiley & Sons, Inc.); Apr2023, Vol. 32 Issue 7/8, p1370-1380, 11p
Publication Year :
2023

Abstract

Aims and Objectives: The self‐performance of a Five‐Times‐Sit‐To‐Stand (FTSTS)‐test, without the usual supervision by a medical professional, provides valuable opportunities for clinical practice and research. This study aimed: (1) to determine the validity of the self‐performed FTSTS test in comparison to a supervised reference test and (2) to determine the reliability of a self‐performed FTSTS test by cancer survivors. Background: Early detection of frailty in cancer survivors may enable prehabilitation interventions before surgery or intensive treatment, improving cancer outcomes. Design: A repeated measures reliability and agreement study, with one week in between measures, was performed. Methods: Cancer survivors (n = 151) performed two FTSTS tests themselves. One additional reference FTSTS test was supervised by a physical therapist. The intraclass correlation coefficient (ICC), structural error of measurement (SEM) and minimally important clinical difference (MID) were calculated comparing a self‐performed FTSTS test to the reference test, and comparing two self‐performed FTSTS tests. The Guidelines for Reporting Reliability and Agreement Studies (GRASS) have been used. Results: Mean age of cancer survivors was 65.6 years (SD = 9.3), 54.6% were female, median time since diagnosis was 2 years [IQR = 1], and tumour type varied (e.g., breast cancer (31.8%), prostate cancer (17.2%), gastrointestinal cancer (11.9%) and haematological cancer (11.9%)). Validity of the self‐performed FTSTS test at home was acceptable in comparison with the reference test (ICC =.74; SEM = 3.2; MID = 3.6) as was the reliability of the self‐performed FTSTS test (ICC =.70; SEM = 2.2; MID = 3.8). Conclusions: The self‐performed FTSTS test is a valid and reliable measure to assess lower body function and has potential to be used as objective (pre‐)screening tool for frailty in cancer survivors. Relevance to clinical practice: The self‐performed FTSTS test at home may indicate the cancer survivors in need of prehabilitation in advance of surgery or intensive treatment. The feasibility, short amount of time needed and potential cost‐effectiveness of the self‐performed FTSTS test can make it a valuable contribution to personalised care and precision medicine. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09621067
Volume :
32
Issue :
7/8
Database :
Complementary Index
Journal :
Journal of Clinical Nursing (John Wiley & Sons, Inc.)
Publication Type :
Academic Journal
Accession number :
162295757
Full Text :
https://doi.org/10.1111/jocn.16299